Goyal, J., Nuhn, P., Huang, P., Tyagi, P., Oh, D., Carducci, M. A., . . . Antonarakis, E. S. (2012). The effect of clinical trial participation versus non-participation on overall survival in men receiving first-line docetaxel-containing chemotherapy for metastatic castration-resistant prostate cancer.
Citação norma ChicagoGoyal, Jatinder, Philipp Nuhn, Peng Huang, Prachi Tyagi, Daniel Oh, Michael A. Carducci, Mario A. Eisenberger, and Emmanuel S. Antonarakis. The Effect of Clinical Trial Participation Versus Non-participation On Overall Survival in Men Receiving First-line Docetaxel-containing Chemotherapy for Metastatic Castration-resistant Prostate Cancer. 2012.
Citação norma MLAGoyal, Jatinder, et al. The Effect of Clinical Trial Participation Versus Non-participation On Overall Survival in Men Receiving First-line Docetaxel-containing Chemotherapy for Metastatic Castration-resistant Prostate Cancer. 2012.